Ftse Mib
33.227,87
0,00%
DAX
19.098,85
0,51%
S&P 500
5.891,40
-0,43%
NASDAQ
18.875,90
-0,48%
Bitcoin
96.304,85
2,06%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adverum Biotechnologies Inc (ADVM) Adverum Biotechnologies Inc (ADVM) Notizie

Adverum Biotechnologies Inc

ADVM
6,045
-0,125 (-2,03%)
Ultimo aggiornamento: 16:14:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202422:05GLOBEAdverum Biotechnologies Reports Inducement Grant Under..
18/11/202422:05EDGAR2Form 8-K - Current report
18/11/202413:00GLOBEAdverum Biotechnologies Announces Positive 52-Week LUNA and..
15/11/202422:05GLOBEAdverum Biotechnologies Announces Webcast to Report 52-Week..
15/11/202400:57EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
15/11/202400:40EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202422:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202422:42EDGAR2Form 8-K - Current report
04/11/202422:39GLOBEAdverum Biotechnologies Reports Third Quarter 2024 Financial..
16/10/202414:00GLOBEAdverum Biotechnologies Appoints Jason L. Mitchell as Chief..
05/9/202413:30GLOBEAdverum Biotechnologies Reports Inducement Grants Under..
04/9/202422:05GLOBEAdverum Biotechnologies to Participate in Upcoming Fall..
12/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:08EDGAR2Form 8-K - Current report
12/8/202422:05GLOBEAdverum Biotechnologies Reports Second Quarter 2024..
06/8/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202413:00GLOBEAdverum Biotechnologies to Participate in the H.C...
01/8/202414:00GLOBEAdverum Biotechnologies Announces FDA Regenerative Medicine..
17/7/202422:38EDGAR2Form 8-K - Current report
17/7/202408:45GLOBEAdverum Biotechnologies Presents Positive Ixo-vec Clinical..
10/7/202414:00GLOBEAdverum Biotechnologies to Host Webcast to Review Clinical..
18/6/202422:07EDGAR2Form 8-K - Current report
18/6/202414:00GLOBEAdverum Biotechnologies to Participate in TD Cowen’s Genetic..
11/6/202422:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/6/202422:16EDGAR2Form 8-K - Current report
11/6/202414:00GLOBEAdverum Biotechnologies Announces Appointments of Dr. Rabia..
28/5/202420:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:10EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEAdverum Biotechnologies Reports First Quarter 2024 Financial..
03/5/202414:00GLOBEAdverum Biotechnologies to Participate in Upcoming May..
25/4/202422:05GLOBEAdverum Biotechnologies to Present LUNA 26-week Phase 2..
18/3/202421:05GLOBEAdverum Biotechnologies Reports Fourth Quarter and Full Year..
04/3/202422:40EDGAR2Form S-3 - Registration statement under Securities Act of..
28/2/202422:05GLOBEAdverum Biotechnologies to Participate in the TD Cowen 44th..
22/2/202421:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/2/202421:39EDGAR2Form D - Notice of Exempt Offering of Securities
15/2/202422:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/2/202402:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202414:00GLOBEAdverum Biotechnologies to Participate in the Oppenheimer..
09/2/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202417:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
Apertura: 6,11 Min: 6,00 Max: 6,17
Chiusura: 6,17

La tua Cronologia

NASDAQ
ADVM
Adverum Biotechnologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network